Seronegative rheumatoid arthritis after combination therapy with ipilimumab and nivolumab for postoperative pancreatic and liver metastases from renal cell carcinoma

Seronegative rheumatoid arthritis after combination therapy with ipilimumab and nivolumab for postoperative pancreatic and liver metastases from renal cell carcinoma

Introduction Since the approval of immune checkpoint inhibitors for renal cell carcinoma treatment, therapeutic efficacy has been enhanced. However, although autoimmune‐related side effects may occur, rheumatoid immune‐related adverse events seldom develop. Case presentation A 78‐year‐old Japanese m...

Full description

Bibliographic Details
Main Authors: Yuki Nishimura, Kazuaki Yamanaka, Taigo Kato, Koji Hatano, Atsunari Kawashima, Shinichiro Fukuhara, Motohide Uemura, Ryoichi Imamura, Norio Nonomura
Format: Article
Language:English
Published: Wiley 2023-03-01
Series:IJU Case Reports
Subjects:
immune‐related adverse event
ipilimumab
nivolumab
renal cell carcinoma
seronegative rheumatoid arthritis
Online Access:https://doi.org/10.1002/iju5.12560

Internet

https://doi.org/10.1002/iju5.12560

Similar Items